Caribou Biosciences (CRBU) Cash from Investing Activities Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | -51.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.43% |
| Dec 31, 2025 | 12.81% |
| Sep 30, 2025 | -59.09% |
| Jun 30, 2025 | 13.38% |
| Mar 31, 2025 | 115.11% |
| Dec 31, 2024 | 150.61% |
| Sep 30, 2024 | 138.73% |
| Jun 30, 2024 | 91.61% |
| Mar 31, 2024 | 10.88% |
| Dec 31, 2023 | -2,790.09% |
| Sep 30, 2023 | -721.15% |
| Jun 30, 2023 | 179.18% |
| Mar 31, 2023 | 128.71% |
| Dec 31, 2022 | 100.67% |
| Sep 30, 2022 | -332.07% |
| Jun 30, 2022 | -2,786.98% |
| Mar 31, 2022 | -327,659.09% |
| Dec 31, 2021 | -28,893.50% |
| Sep 30, 2021 | -48,150.00% |